FEMY
Femasys Inc. (NASDAQ)
Healthcare — Medical Instruments & Supplies
Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation. It also provides FemBloc, a non-surgical female permanent birth control solution. The company offers its products to gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.
Price History
Fundamentals
| Market Cap | $13.13M |
| P/E Ratio (TTM) | - |
| Forward P/E | -0.75 |
| EPS (TTM) | $-4.80 |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | 24.50% |
| ROE | -255.96% |
| Debt/Equity | 64.86 |
| Recommendation | None |
| Analyst Target | $63.33 |
| Analysts | - |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 43.4 |
| Beta | -2.22 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $22.20 |
| 52-Week Low | $3.50 |
| 50-Day Avg | $6.52 |
| 200-Day Avg | $10.84 |
| Avg Volume | 61.4K |
| Volume | 51.5K |
Performance Analysis
BULLISHFEMY shows predominantly bullish signals based on its fundamentals and technicals.
Recent News
Last updated: Jul 02, 2026 13:09 UTC
Back to Screener Export Report